tiprankstipranks
Amneal Pharma (AMRX)
:AMRX
US Market

Amneal Pharmaceuticals (AMRX) Income Statement

Compare
527 Followers

Amneal Pharmaceuticals Income Statement

Last quarter (Q4 2024), Amneal Pharmaceuticals's total revenue was $730.52M, an increase of 18.40% from the same quarter last year. In Q4, Amneal Pharmaceuticals's net income was $-31.08M. See Amneal Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 2.79B$ 2.39B$ 2.21B$ 2.09B$ 1.99B
Gross Profit
$ 1.02B$ 820.57M$ 784.71M$ 768.97M$ 628.39M
Operating Expenses
$ 771.11M$ 616.19M$ 595.79M$ 575.07M$ 517.31M
Depreciation and Amortization
$ 236.19M$ 229.40M$ 240.18M$ 233.41M$ 235.39M
EBITDA
$ 439.77M$ 399.76M$ 150.43M$ 450.00M$ 381.05M
Operating Income
$ 249.33M$ 204.37M$ 206.46M$ 209.24M$ 91.16M
Other Income/Expenses
$ -304.34M$ -244.64M$ -153.20M$ -121.35M$ -126.94M
Pretax Income
$ -55.01M$ -40.27M$ -248.13M$ 31.37M$ -35.78M
Net Income
$ -116.89M$ -83.99M$ -254.79M$ 20.17M$ 68.58M
Per Share Metrics
Basic EPS
$ -0.38$ -0.48$ -1.69$ 0.14$ 0.47
Diluted EPS
$ -0.38$ -0.48$ -1.69$ 0.13$ 0.46
Weighted Average Shares Outstanding
308.98M 174.99M 150.94M 148.92M 147.44M
Weighted Average Shares Outstanding (Diluted)
308.98M 176.14M 150.94M 151.82M 148.91M
Currency in USD

Amneal Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis